AXATILIMAB-CSFR

AXATILIMAB-CSFR was reported 163 times

AXATILIMAB-CSFR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIVER IRON CONCENTRATION ABNORMAL 1 0.0400
1 SUBMANDIBULAR ABSCESS 1 0.0167
2 GRAFT VERSUS HOST DISEASE ORAL 1 0.0156
3 RASH FOLLICULAR 1 0.0065
4 CHEST TUBE INSERTION 1 0.0053
5 CORNEAL INFECTION 1 0.0046
6 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
7 GRAFT VERSUS HOST DISEASE IN LUNG 2 0.0042
8 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
9 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
10 BLAST CELLS PRESENT 1 0.0021
11 GLARE 1 0.0019
12 ALVEOLAR PROTEINOSIS 1 0.0017
13 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
14 VEIN COLLAPSE 1 0.0013
15 CREATINE KINASE INCREASED 1 0.0013
16 PSEUDOMONAS TEST POSITIVE 1 0.0012
17 HYPERMETROPIA 1 0.0011
18 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
19 BLOOD FIBRINOGEN DECREASED 1 0.0009
20 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
21 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
22 SYMPTOM RECURRENCE 4 0.0007
23 ACUTE LEUKAEMIA 1 0.0006
24 AUTOIMMUNE HAEMOLYTIC ANAEMIA 2 0.0006
25 GRAFT VERSUS HOST DISEASE 4 0.0006
26 BLOOD IRON INCREASED 1 0.0005
27 SKIN INDURATION 1 0.0005
28 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
29 MYOPIA 1 0.0004
30 LIPASE INCREASED 3 0.0004
31 PROTEIN TOTAL INCREASED 1 0.0004
32 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
33 LIVER FUNCTION TEST INCREASED 7 0.0003
34 BLOOD CREATININE DECREASED 1 0.0003
35 BK VIRUS INFECTION 1 0.0003
36 HYPERTRANSAMINASAEMIA 2 0.0003
37 AMYLASE INCREASED 1 0.0003
38 BLEPHARITIS 1 0.0002
39 CYSTITIS HAEMORRHAGIC 1 0.0002
40 ANAPHYLACTOID REACTION 1 0.0002
41 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
42 CARDIAC TAMPONADE 1 0.0002
43 PERIORBITAL OEDEMA 1 0.0002
44 NONSPECIFIC REACTION 1 0.0002
45 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
46 PRODUCT PREPARATION ISSUE 1 0.0002
47 ASPERGILLUS INFECTION 1 0.0002
48 PULMONARY MASS 2 0.0001
49 INSURANCE ISSUE 2 0.0001
50 MUSCLE STRAIN 1 0.0001
51 INFUSION RELATED REACTION 7 0.0001
52 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
53 ATELECTASIS 1 0.0001
54 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
55 WEIGHT FLUCTUATION 1 0.0001
56 FULL BLOOD COUNT ABNORMAL 1 0.0001
57 BLOOD GLUCOSE FLUCTUATION 1 0.0001
58 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
59 TACHYPNOEA 1 0.0001
60 ANAPHYLACTIC REACTION 4 0.0001
61 BRONCHOSPASM 1 0.0001
62 MYELODYSPLASTIC SYNDROME 1 0.0001
63 IMMUNODEFICIENCY 1 0.0001
64 DISEASE RECURRENCE 3 0.0001
65 CANDIDA INFECTION 1 0.0001
66 PANCREATITIS 3 0.0001
67 LYMPHOCYTE COUNT DECREASED 1 0.0001
68 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
69 BACTERIAL INFECTION 1 0.0001
70 DYSPNOEA EXERTIONAL 2 0.0001
71 PRODUCT ADMINISTRATION ERROR 1 0.0000
72 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
73 PRODUCT PREPARATION ERROR 1 0.0000
74 EATING DISORDER 1 0.0000
75 RASH MACULO-PAPULAR 1 0.0000
76 PRODUCT AVAILABILITY ISSUE 1 0.0000
77 OFF LABEL USE 38 0.0000
78 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
79 PRODUCT PRESCRIBING ERROR 1 0.0000
80 PRESYNCOPE 1 0.0000
81 ABDOMINAL PAIN LOWER 1 0.0000
82 BLOOD BILIRUBIN INCREASED 1 0.0000
83 CATARACT 2 0.0000
84 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
85 HEPATIC FAILURE 1 0.0000
86 HEPATIC ENZYME INCREASED 2 0.0000
87 DELIRIUM 1 0.0000
88 RASH MACULAR 1 0.0000
89 HYPOXIA 1 0.0000
90 HYPERGLYCAEMIA 1 0.0000
91 PANIC ATTACK 1 0.0000
92 RESTLESSNESS 1 0.0000
93 PRODUCT DOSE OMISSION ISSUE 8 0.0000
94 RHABDOMYOLYSIS 1 0.0000
95 TACHYCARDIA 2 0.0000
96 THERAPY NON-RESPONDER 1 0.0000
97 SKIN DISCOLOURATION 1 0.0000
98 INFECTION 3 0.0000
99 DRY EYE 1 0.0000
100 CELLULITIS 1 0.0000
101 ILLNESS 2 0.0000
102 ABDOMINAL DISTENSION 2 0.0000
103 OEDEMA 1 0.0000
104 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
105 URTICARIA 3 0.0000
106 DYSPHONIA 1 0.0000
107 STOMATITIS 1 0.0000
108 ILL-DEFINED DISORDER 1 0.0000
109 CONDITION AGGRAVATED 5 0.0000
110 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
111 VISION BLURRED 2 0.0000
112 RESPIRATORY FAILURE 1 0.0000
113 AGITATION 1 0.0000
114 BRONCHITIS 1 0.0000
115 DYSGEUSIA 1 0.0000
116 WEIGHT INCREASED 3 0.0000
117 CARDIAC FAILURE 1 0.0000
118 THROMBOSIS 1 0.0000
119 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
120 URINARY TRACT INFECTION 2 0.0000
121 DYSPNOEA 6 0.0000
122 PRURITUS 4 0.0000
123 ALOPECIA 2 0.0000
124 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
125 CHEST DISCOMFORT 1 0.0000
126 HAEMOGLOBIN DECREASED 1 0.0000
127 HAEMORRHAGE 1 0.0000
128 PNEUMONIA 3 0.0000
129 INFLUENZA 1 0.0000
130 SEPSIS 1 0.0000
131 THROMBOCYTOPENIA 1 0.0000
132 MUSCULAR WEAKNESS 1 0.0000
133 BACK PAIN 2 0.0000
134 CHILLS 1 0.0000
135 VOMITING 4 0.0000
136 OEDEMA PERIPHERAL 1 0.0000
137 VISUAL IMPAIRMENT 1 0.0000
138 DIARRHOEA 5 0.0000
139 FATIGUE 6 0.0000
140 NAUSEA 6 0.0000
141 WEIGHT DECREASED 2 0.0000
142 DEATH 6 0.0000
143 HYPOAESTHESIA 1 0.0000
144 BLOOD PRESSURE INCREASED 1 0.0000
145 HOSPITALISATION 1 0.0000
146 PERIPHERAL SWELLING 1 0.0000
147 PARAESTHESIA 1 0.0000
148 CEREBROVASCULAR ACCIDENT 1 0.0000
149 MYALGIA 1 0.0000
150 CHEST PAIN 1 0.0000
151 HYPERSENSITIVITY 1 0.0000
152 PRODUCT USE ISSUE 1 0.0000
153 ANAEMIA 1 0.0000
154 HEADACHE 3 0.0000
155 RASH 2 0.0000
156 CONSTIPATION 1 0.0000
157 INCORRECT DOSE ADMINISTERED 1 0.0000
158 DECREASED APPETITE 1 0.0000
159 ABDOMINAL PAIN 1 0.0000
160 FEELING ABNORMAL 1 0.0000
161 ANXIETY 1 0.0000
162 PAIN IN EXTREMITY 1 0.0000
163 PAIN 2 0.0000
164 PYREXIA 1 0.0000
165 ASTHENIA 1 0.0000
166 ARTHRALGIA 1 0.0000
167 DRUG INEFFECTIVE 3 0.0000